Adaptimmune Therapeutics
ADAP
#9234
Rank
S$96.05 M
Marketcap
$0.36
Share price
4.45%
Change (1 day)
-76.87%
Change (1 year)

Adaptimmune Therapeutics (ADAP) - Cash on Hand

Cash on Hand as of December 2024 : S$0.19 Billion

According to Adaptimmune Therapeutics's latest financial reports the company has S$0.19 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Adaptimmune Therapeutics - Cash on Hand chart (from 2014 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31S$0.19 B-29.25%
2022-12-31S$0.27 B-45.1%
2021-12-31S$0.49 B2.57%
2020-12-31S$0.48 B303.52%
2019-12-31S$0.12 B-56.92%
2018-12-31S$0.28 B0.61%
2017-12-31S$0.27 B6.06%
2016-12-31S$0.26 B
2015-06-30S$0.38 B497.67%
2014-06-30S$64.07 M20307.32%
2013-06-30S$0.31 M-91.8%
2012-06-30S$3.83 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
S$1.20 B 508.90%๐Ÿ‡บ๐Ÿ‡ธ USA
S$52.71 M-73.42%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.48 B 142.42%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
S$1.45 B 633.01%๐Ÿ‡บ๐Ÿ‡ธ USA